Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJohn K. Troyer, Mary Lou Beckett, George L. Wright
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
1994
Prostate cancer: An overview of an increasing dilemma
10.1002/1097-0142(19930201)71:3+<880::aid-cncr2820711403>3.0.co;2-6 · 1993
The prostate: An increasing medical problem
10.1002/pros.2990160302 · 1990
Biological markers in urologic cancer
10.1002/1097-0142(19870801)60:3+<464::aid-cncr2820601506>3.0.co;2-c · 1987
Prostate specific antigen, digital rectal exam, and transrectal ultrasonography: Their roles in diagnosing early prostate cancer
1993
Clinical stage BO or Tlc prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentration
10.1016/0090-4295(93)90233-z · 1993
Local failure after definitive radiation or surgical therapy for carcinoma of the prostate and options for prevention and therapy
10.1016/s0094-0143(21)00342-6 · 1991
Monoclonal antibodies to a new antigenic marker in epithelial prostate cells and serum of prostatic cancer patients
1987
Characterization of a new prostate carcinoma-associated marker:7E11-C5
1990
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen
1993
Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5
1990
Immunoscintigraphy of prostatic cancer: Preliminary results with 111ln-labeled monoclonal antibody 7E11-C5.3 (CYT-356)
10.1002/pros.2990180305 · 1991
Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence
10.1016/s0022-5347(17)32453-9 · 1994
Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356
10.1016/s0022-5347(17)32277-2 · 1994
Subcellular localization of the 7E11-C5 prostate specific antigen
1994
Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation
10.1016/0022-1759(85)90337-0 · 1985
Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas
10.4049/jimmunol.135.5.3610 · 1985
Human prostate tissue antigens defined by murine monoclonal antibodies
1986
Isolation and characterization of Jack Bean Beta-galactosidase
10.1016/s0021-9258(19)41000-4 · 1975
Deglycosylation of asparagine linked glycans by peptide N-glycosidase F
10.1021/bi00338a028 · 1985
Purification and properties of bacterial chondroitinases and chondrosulfases
10.1016/s0021-9258(18)93574-x · 1968
Characterization of a monoclonal antibody against human prolactin receptors
10.1002/ijc.2910550503 · 1993
Measurement of antibody binding to antigenic peptides conjugated in situ to albumin-coated microtiter plates
10.1016/0022-1759(93)90168-7 · 1993
Detection of lectin binding to glycoconjugates immobilized on polyvinyl chloride microtitre plates
1981
The attractions of proteins for small molecules and ions
10.1111/j.1749-6632.1949.tb27297.x · 1949
Purification and biochemical characterization of the 7E11-C5 prostate carcinoma-associated antigen
1991
Molecular characterization of the 7E11-C5 prostate tumorassociated antigen
1993
Expression of the prostate-specific membrane antigen
1994
Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies
1990
The periodate oxidation of amino acids with reference to studies on glycoproteins
10.1042/bj0940017 · 1965
Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients
10.1002/pros.2990250408 · 1994
No additional external references are available.